TIDES: Oligonucleotides and Peptide Therapeutics
Monday, May 20th – Thursday, May 23rd
Registration starts on Monday at 7:00A.M.

Manchester Grand Hyatt
1 Market Pl
San Diego, California 92101

A couple of EpiVax team members are attending TIDES in San Diego this Spring. On May 20 at 3:00P.M, Dr. Annie De Groot will be presenting “Of Peptides and PANDAS: Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics.” We encourage you to come sit in her presentation and ask questions.

VIEW OUR SUBMITTED ABSTRACT HERE!

Later in the week, during the after-hours of the conference, you are invited to join us for a small party at Puesto at the Headquarters. Seating is limited, so RSVP today!

REGISTER HERE FOR OUR TIDES PARTY!

ABOUT OUR PRESENTATION:

In response to the recent FDA guidance, which outlined new immunogenicity assessment requirements for synthetic generic peptide drugs, EpiVax has developed the PANDA (Peptide Abbreviated New Drug Application) program. Our proprietary screening technology is a multi-step approach to assessing the immunogenicity of RLDs. These steps include an initial in silico assessment, followed by in vitro validation, and lastly, a full literature review.

LEARN MORE ABOUT EPIVAX’S PANDA SCREENING TECHNOLOGY! 

ABOUT THE EVENT:

TIDES is the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development and commercialization. Over 1000 oligonucleotide and peptide scientists will be present. Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.

With 125+ case studies and new data presentations, you are bound to hear the best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.

To learn more about the conference, visit TIDES’ official event page.